MANNKIND CORP Impairment of Long-Lived Assets to be Disposed of
MANNKIND CORP (MNKD) reported Impairment of Long-Lived Assets to be Disposed of of $100.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2023-02-23
- MANNKIND CORP impairment of long-lived assets to be disposed of for the quarter ending 2020-03-31 was $1.52M.
- MANNKIND CORP impairment of long-lived assets to be disposed of for fiscal 2021 was $100.00K, a 94.71% decline from fiscal 2020.
- MANNKIND CORP impairment of long-lived assets to be disposed of for fiscal 2020 was $1.89M.
- MANNKIND CORP impairment of long-lived assets to be disposed of for fiscal 2019 was $0.00.
- MANNKIND CORP impairment of long-lived assets to be disposed of for fiscal 2018 was $0.00.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|
| 2021-12-31 | $100.00K 10-K · filed 2023-02-23 | |
| 2020-12-31 | $1.89M 10-K · filed 2021-02-25 | |
| 2020-03-31 | $1.52M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |